Precision Neuroscience Raises $102 Million to Advance AI-Powered Brain ImplantSeries C Funding Round Establishes Precision as the Best-Funded Brain–Computer Interface Company After Neuralink

Precision Neuroscience筹集1.02亿美元用于推进人工智能驱动的大脑植入C系列资金回合，使Precision成为继Neuralink之后资金最多的大脑-计算机接口公司

• The raise brings Precision’s total funding to $155 million, solidifying its position as a leader in the brain–computer interface industry.

•此次加薪使Precision的总资金达到1.55亿美元，巩固了其在脑机接口行业的领先地位。

• Investors include General Equity Holdings, B Capital, Stanley F. Druckenmiller’s Duquesne Family Office, and Steadview Capital.

•投资者包括General Equity Holdings、B Capital、Stanley F.Druckenmiller的Duquesne家族理财办公室和Steadview Capital。

• Precision will use the funds to advance its clinical research and expedite development of its cutting-edge brain implant, which is designed to enable paralyzed people to operate computers with their thoughts.NEW YORK, December 16, 2024-- Today, brain–computer interface (BCI) company Precision Neuroscience Corporation (Precision), announced the successful closing of a $102 million Series C funding round led by General Equity Holdings, with participation from firms including B Capital; Duquesne Family Office, the investment firm of Stanley F.

•Precision将利用这些资金推进其临床研究，并加快其尖端大脑植入物的开发，该植入物旨在使瘫痪的人能够用他们的想法操作计算机。2024年12月16日，纽约——今天，脑-计算机接口（BCI）公司Precision Neuroscience Corporation（Precision）宣布，由General Equity Holdings牵头的一轮1.02亿美元的C系列融资圆满结束，包括B Capital在内的公司参与了这轮融资；Duquesne家族理财办公室，斯坦利F的投资公司。

Druckenmiller; and Steadview Capital. With $155 million in total capital raised, Precision is now one of the best-funded companies in the BCI industry..

德鲁肯米勒；和Steadview Capital。凭借1.55亿美元的总融资，Precision现在是BCI行业资金最雄厚的公司之一。

Precision will use the new financing to expand its team, advance its clinical research efforts, and refine future versions of its AI-powered brain implant, which is designed to enable users with severe paralysis to operate digital devices, such as computers and smartphones, using only their thoughts.

Precision将利用新资金扩大团队规模，推进临床研究工作，并改进其人工智能大脑植入物的未来版本，该植入物旨在使严重瘫痪的用户能够仅使用自己的想法操作计算机和智能手机等数字设备。

In coming years, this system has the potential to change what it means to be physically disabled, breaking down barriers to communication, employment, and independence..

在未来几年，这个系统有可能改变身体残疾的含义，打破沟通、就业和独立的障碍。

Precision’s roadmap extends beyond motor paralysis, to meeting the needs of millions of people living with neurological conditions ranging from obsessive compulsive disorder to depression. “We’re beginning by addressing some of the most debilitating disorders—severe spinal cord injury, stroke, ALS—and our goal is to develop a product that is safe enough, and scalable enough, to treat a broad range of neurological conditions,” Michael Mager, the company’s co-founder and CEO, said.

Precision的路线图超越了运动麻痹，满足了数百万患有从强迫症到抑郁症等神经系统疾病的人的需求。该公司联合创始人兼首席执行官迈克尔·马格（MichaelMager）表示：“我们正在着手解决一些最令人衰弱的疾病，包括严重的脊髓损伤、中风、肌萎缩侧索硬化症，我们的目标是开发一种足够安全、可扩展的产品，以治疗多种神经系统疾病。”。

“This funding brings us one step closer to that vision.”.

“这笔资金使我们更接近这一愿景。”

The brain–computer interface field is attracting growing interest from investors. Morgan Stanley recently estimated the commercial BCI market could reach $400 billion in the U.S. alone. Andrew Bellas, managing partner of General Equity Holdings, said, “BCI technology is truly at an inflection point.

脑-机接口领域正吸引着越来越多的投资者。摩根士丹利最近估计，仅在美国，商业BCI市场就可能达到4000亿美元。General Equity Holdings管理合伙人安德鲁·贝拉斯（AndrewBellas）表示：“BCI技术确实处于拐点。

Advances in both hardware and software are unlocking ways to connect with the brain that were previously unimaginable. We believe Precision has an outstanding team whose approach to this technology is cutting-edge while remaining focused on the needs of the end user. Over the coming years, BCI’s impact is likely to be massive, both in medicine and beyond.”.

硬件和软件的进步正在解锁以前无法想象的与大脑连接的方式。我们相信，Precision拥有一支优秀的团队，其技术方法是前沿的，同时仍然专注于最终用户的需求。在未来几年中，BCI在医学和其他领域的影响可能是巨大的。”

“Precision’s technology enables the human brain to tell a machine what to do,” Kevin Warsh, Partner at Duquesne Family Office, said. “Ben, Michael, and their team are creating something at the frontier of neural research and machine learning. Expect drastically improved lives for millions of people and markedly improved knowledge for the world.

Duquesne家族理财办公室合伙人凯文·沃什（KevinWarsh）说：“Precision的技术使人脑能够告诉机器该做什么。”。“本、迈克尔和他们的团队正在神经研究和机器学习的前沿创造一些东西。预计数百万人的生活会大大改善，世界的知识也会显著提高。

We are thrilled to be their partner.”.

我们很高兴成为他们的合作伙伴。”

Dr. Robert Mittendorff, General Partner and Head of Healthcare at B Capital, said, “As longtime investors in Precision, it has been incredible and rewarding to watch how quickly the company has revolutionized the neurological field with its proprietary BCI technology. We focus on backing the most innovative founders transforming the healthcare industry, and we are thrilled to continue supporting Ben, Michael, and the full Precision team as they develop critical treatments and bring their AI-powered brain implant to the market.”.

B Capital的普通合伙人兼医疗保健主管罗伯特·米特多夫博士表示：“作为精准领域的长期投资者，看到该公司凭借其专有的脑机接口技术迅速改变了神经领域，这是令人难以置信的，也是值得的。我们专注于支持最具创新精神的创始人改变医疗保健行业，我们很高兴继续支持Ben，Michael和整个精准团队开发关键治疗方法，并将其人工智能脑植入物推向市场。”

Founded in 2021 and led by a team that includes Ben Rapoport—a neurosurgeon-engineer and former co-founder of Neuralink—Precision has developed the first BCI system to combine high-bandwidth data transfer, enabling complex tasks to be performed through thought, with a minimally invasive surgical approach.

成立于2021年，由包括神经外科医生工程师Ben Rapoport和Neuralink Precision前联合创始人在内的团队领导，开发了第一个结合高带宽数据传输的BCI系统，使复杂任务能够通过思想和微创手术方法执行。

In just a few years, the company has achieved significant milestones:.

在短短几年内，该公司取得了重大里程碑：。

• Built and validated a BCI system that uniquely combines powerful bandwidth with patient safety.

•构建并验证了一个BCI系统，该系统将强大的带宽与患者安全独特地结合在一起。

• Recruited a team of 70+ experts across diverse disciplines.

•招募了一支由70多名不同学科的专家组成的团队。

• Raised $155 million from leading investors.

•从主要投资者那里筹集了1.55亿美元。

• Successfully tested its device in 27 patients through research partnerships with prominent medical institutions, including Mount Sinai Health System, the Perelman School of Medicine at the University of Pennsylvania, and West Virginia University’s Rockefeller Neuroscience Institute, with additional partnerships forthcoming. .

•通过与著名医疗机构（包括西奈山卫生系统、宾夕法尼亚大学佩雷尔曼医学院和西弗吉尼亚大学洛克菲勒神经科学研究所）的研究合作，成功地在27名患者中测试了其设备，并即将建立其他合作伙伴关系。

• Acquired a state-of-the-art manufacturing facility in Texas to fabricate its implants.

•在德克萨斯州收购了一家最先进的制造工厂，以制造其植入物。

• Secured FDA Breakthrough Device designation.

•获得FDA突破性设备指定。

• Expanded its executive leadership team, appointing former Verily co-founder Brian Otis as Chief Technology Officer, Mike Kaswan as Chief Financial Officer, and Jayme Strauss as Chief Clinical and Commercial Officer.

•扩大了执行领导团队，任命前Verily联合创始人Brian Otis为首席技术官，Mike Kaswan为首席财务官，Jayme Strauss为首席临床和商业官。

Precision’s brain implant is an investigational device that is not available for sale in the United States.

Precision的大脑植入物是一种研究设备，在美国无法销售。

About Precision:

关于精度：

Precision Neuroscience is dedicated to developing breakthrough treatments for neurological disorders affecting millions of people worldwide. The company is pioneering the only brain–computer interface designed to be minimally invasive, safely removable, and capable of processing large amounts of neural data.

Precision Neuroscience致力于为影响全球数百万人的神经系统疾病开发突破性治疗方法。。

To learn more about how Precision is connecting human intelligence and artificial intelligence, visit www.precisionneuro.io.Contact: .

要了解精度如何将人类智能和人工智能联系起来的更多信息，请访问www.precisionneuro.io.Contact：

Media Contact:

媒体联系人：

media@precisionneuro.io

media@precisionneuro.io